tiprankstipranks
Trending News
More News >
Abeona Therapeutics (ABEO)
NASDAQ:ABEO
US Market

Abeona Therapeutics (ABEO) Income Statement

Compare
1,462 Followers

Abeona Therapeutics Income Statement

Last quarter (Q3 2025), Abeona Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Abeona Therapeutics's net income was $-5.16M. See Abeona Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 3.50M$ 1.41M$ 3.00M$ 10.00M
Gross Profit
$ -2.91M$ 1.90M$ 964.00K$ 3.00M$ 10.00M
Operating Expenses
$ 61.30M$ 49.03M$ 51.88M$ 92.84M$ 91.42M
Depreciation and Amortization
$ 2.91M$ 3.20M$ 4.58M$ 4.46M$ 5.60M
EBITDA
$ -56.62M$ -50.57M$ -34.38M$ -76.82M$ -74.52M
Operating Income
$ -64.21M$ -47.13M$ -50.91M$ -89.84M$ -81.42M
Other Income/Expenses
$ 477.00K$ -7.05M$ 11.22M$ 4.90M$ -2.81M
Pretax Income
$ -63.73M$ -54.19M$ -39.70M$ -84.94M$ -84.23M
Net Income
$ -63.73M$ -54.19M$ -39.70M$ -84.94M$ -84.23M
Per Share Metrics
Basic EPS
$ -1.55$ -2.53$ -5.53$ -21.50$ -22.75
Diluted EPS
$ -1.55$ -2.53$ -5.53$ -21.50$ -22.75
Weighted Average Shares Outstanding
41.05M 21.38M 7.86M 3.94M 3.71M
Weighted Average Shares Outstanding (Diluted)
41.05M 21.38M 7.86M 3.94M 3.71M
Currency in USD

Abeona Therapeutics Earnings and Revenue History